Table 1.
Characteristics of the vaccinated SARS-CoV-2 cohorts
| SARS-CoV-2 naive |
SARS-CoV-2 previously infected |
||
|---|---|---|---|
| Two doses Short interval (n = 19) |
Two doses Long interval (n = 25) |
Two doses Long interval (n = 15) |
|
| Age | 39 (20–74) | 50 (21–62) | 47 (29–65) |
| Sex | |||
| Male (n) | 12 | 11 | 10 |
| Female (n) | 7 | 14 | 5 |
| Days between symptom onset and V0a | N/A | N/A | 191 (85–234) |
| Days between symptom onset and the 1st dosea | N/A | N/A | 274 (166–321) |
| Days between the 1st and 2nd dosea | 29 (22–34) | 111 (76–120) | 110 (90–134) |
| Days between the 2nd dose and V3a | 22 (12–53) | 21 (14–34) | 22 (13–51) |
| Days between the 2nd dose and V4a | N/A | 112 (103–125) | 113 (90–127) |
a
Values displayed are medians, with ranges in parentheses.